Beijing Geekgene Technology Co., Ltd
Clinical trials sponsored by Beijing Geekgene Technology Co., Ltd, explained in plain language.
-
New cell injection tested for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing the safety and initial effects of an experimental cell therapy called GK01. It is for adults with advanced lung cancer or esophageal cancer that has not improved with standard treatments. Researchers will give participants a single infusion of th…
Phase: EARLY_PHASE1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test Patient's own cells to fight cancer fluid
Disease control Recruiting nowThis is a very early, small study to see if a new personalized cell therapy is safe and shows any early signs of working. It is for people with advanced cancers who have developed a painful buildup of fluid in the abdomen (malignant ascites). Doctors will collect a patient's own …
Phase: EARLY_PHASE1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC